MACCALLINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 5.487
EU - Europa 3.978
AS - Asia 3.676
SA - Sud America 367
AF - Africa 57
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.571
Nazione #
US - Stati Uniti d'America 5.348
SG - Singapore 1.407
CN - Cina 1.002
IT - Italia 909
IE - Irlanda 486
TR - Turchia 444
UA - Ucraina 427
SE - Svezia 424
RU - Federazione Russa 375
VN - Vietnam 331
GB - Regno Unito 313
BR - Brasile 306
FR - Francia 306
IN - India 265
DE - Germania 230
PL - Polonia 149
FI - Finlandia 120
CA - Canada 94
AT - Austria 69
ES - Italia 46
HK - Hong Kong 39
JP - Giappone 31
MX - Messico 28
BD - Bangladesh 25
CZ - Repubblica Ceca 25
BE - Belgio 22
LT - Lituania 20
NL - Olanda 20
ZA - Sudafrica 20
PK - Pakistan 16
AR - Argentina 15
KR - Corea 14
ID - Indonesia 12
IQ - Iraq 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 9
CO - Colombia 9
CL - Cile 8
SA - Arabia Saudita 8
KE - Kenya 7
MA - Marocco 7
MY - Malesia 7
PH - Filippine 7
PT - Portogallo 7
TW - Taiwan 7
EC - Ecuador 5
GR - Grecia 5
IL - Israele 5
UZ - Uzbekistan 5
AU - Australia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
HR - Croazia 4
IR - Iran 4
JO - Giordania 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
AL - Albania 3
CR - Costa Rica 3
JM - Giamaica 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
YE - Yemen 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DK - Danimarca 2
KZ - Kazakistan 2
NP - Nepal 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SO - Somalia 1
Totale 13.569
Città #
Singapore 1.067
Chandler 605
San Jose 564
Jacksonville 511
Dublin 477
Ashburn 465
Izmir 282
Beijing 249
Dearborn 233
Dallas 221
Chieti 211
Southend 198
Princeton 194
Nanjing 150
The Dalles 136
Los Angeles 129
Santa Clara 122
Ann Arbor 119
Ho Chi Minh City 112
Kraków 108
Cambridge 103
Wilmington 96
New York 77
Hanoi 69
Nanchang 66
Pescara 63
Altamura 62
Vienna 56
Tongling 55
Munich 53
Buffalo 52
Moscow 49
Boardman 47
Bosa 40
São Paulo 40
Houston 37
Warsaw 37
Shenyang 34
Hong Kong 33
Orem 33
Teramo 33
Atlanta 32
Woodbridge 32
Hebei 31
Helsinki 31
Jiaxing 30
Brooklyn 29
Kocaeli 28
Redondo Beach 28
Tianjin 28
Chennai 26
Denver 26
Kunming 26
Tokyo 26
Jinan 25
Brno 23
Council Bluffs 23
Hefei 23
Montreal 23
Rome 23
Toronto 23
Brussels 22
Milan 21
Ottawa 21
Washington 21
Changsha 20
Da Nang 20
Stockholm 20
Fairfield 19
London 19
Ningbo 18
Hangzhou 17
Poplar 16
Frankfurt am Main 15
Turku 15
Nuremberg 14
Haiphong 13
Johannesburg 13
Rio de Janeiro 13
Bologna 12
Falls Church 12
Guangzhou 12
Norwalk 12
Phoenix 12
Ankara 11
Dong Ket 11
Amsterdam 10
Biên Hòa 10
Chicago 10
Como 10
Mexico City 10
New Delhi 10
San Francisco 10
Seattle 10
Augusta 9
Manchester 9
Mumbai 9
Orange 9
Zhengzhou 9
Auburn Hills 8
Totale 8.356
Nome #
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 250
Anticancer Activity of Stilbene-Based Derivatives 189
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 188
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 187
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 186
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 176
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 173
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 168
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 168
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 166
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 164
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 161
Recent developments of amidine-like compounds as selective NOS inhibitors 160
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 159
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 158
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 158
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 156
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 156
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 155
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 155
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 154
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 154
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 148
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 148
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 146
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools 146
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 146
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 145
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 145
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 143
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 142
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 140
Synthesis and antiplatelet activity of clofibric acid analogues 139
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 139
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 139
Synthetic Strategies to Serine-Proline Chimeras: An Overview 139
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 136
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 136
Convergent Solution Phase and Solid Phase Synthesis for the Preparation of beta- Lactam antibiotic libraries. 135
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 134
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 134
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 132
Amidine-Based Compounds Affecting L-Arginine Metabolism 130
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 129
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 129
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 128
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 128
null 128
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 128
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 127
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 127
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 126
Structural development studies of PPARs ligands based on tyrosine scaffold 126
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 126
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 124
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 123
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 123
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 123
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 123
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 123
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 122
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 122
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 120
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 119
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 118
Synthesis of potential dual binding site acetylcholinesterase inhibitors through an efficient solid phase approach based on the Mitsunobu reaction 118
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 117
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 117
Synthetic methodologies for the preparation of arginine-proline derivatives 116
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 114
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer 113
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 110
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 110
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 109
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 109
Targeting iNOS As a Valuable Strategy for the Therapy of Glioma 108
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 108
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 107
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 107
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 107
N-substituted acetamidines as nitric oxide synthase inhibitors 106
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 105
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 104
“Insight into diastereospecific solvolysis of peptidyl-b-lactams: combined kinetic and conformational studies” 104
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 102
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 102
Methods to Evaluate the Activity of Nitric Oxide Synthase 101
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 101
Choline Chloride-Based DES as Solvents/Catalysts/Chemical Donors in Pharmaceutical Synthesis 101
Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity 100
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 100
Acetamidine-Based iNOS Inhibitors as Molecular Tools to Counteract Inflammation in BV2 Microglial Cells 100
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 99
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 96
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 93
CAPE derivatives: Multifaceted agents for chronic wound healing 92
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 92
Insights into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 92
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 90
N-Acylsulfonylamides as a new class of PPARa antagonists 90
Totale 13.065
Categoria #
all - tutte 50.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021169 0 0 0 0 0 0 0 0 0 105 14 50
2021/2022661 13 13 22 105 70 18 24 49 97 30 71 149
2022/20231.712 124 243 127 169 162 345 88 129 213 21 56 35
2023/2024791 56 26 73 21 48 250 192 10 3 30 8 74
2024/20252.063 92 394 348 46 37 95 116 124 176 94 269 272
2025/20264.192 354 150 411 600 538 263 808 306 477 285 0 0
Totale 14.186